Skip to main content

Early-stage discoveries for Serratiopeptidase

By November 2, 2023No Comments

Good results in lab and pilot studies lead to larger human trials. Here are some of the most promising recent findings.

  • Serratiopeptidase reduced vessel inflammation

Standard anti-inflammatory medications for inflammatory conditions have serious long-term adverse effects. In the lab, doctors gave the anti-inflammatory super-enzyme, serratiopeptidase (SRP), to mice with blood vessel inflammation. In aortic tissue, levels of a pro-inflammatory bacterial toxin, lipopolysaccharides (LPS), linked to heart disease, decreased significantly, along with the pro-inflammatory cytokines Interleukin-1, -2, and -6, and tumor necrosis factor-alpha.

Reference: Current Issues in Molecular Biology; 2023, Vol. 45, No. 3 101097, 1441

Get additional sales, coupons, recipes, info on events & more!

Join our mailing list

Check your email (junk & spam too!) to confirm your subscription.